Showing results (291-300 of 338) with videos related to
Sort By:
Pageof 34
Cancer|June 8, 2012
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trialJong-Mu Sun, Ki Hyeong Lee, Sang-We Kim, et al.Annals of Hematology|September 8, 2010
High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignanciesJun Kang, Jeong Hyun Cho, Cheol Won Suh, et al.Oncoimmunology|January 4, 2018
Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancerHye In Kim, Mijin Kim, Se-Hoon Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2005
Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter studyJeeyun Lee, Cheolwon Suh, Yeon Hee Park, et al.JAMA Oncology|September 2, 2021
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical TrialLeora Horn, Ziping Wang, Gang Wu, et al.Therapeutic Advances in Medical Oncology|October 24, 2024
BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancerSun Min Lim, Stefanie S Schalm, Eun Ji Lee, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 25, 2012
The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directivesBhumsuk Keam, Young Ho Yun, Dae Seog Heo, et al.Clinical Lung Cancer|May 23, 2015
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative ResectionChanghoon Yoo, Shinkyo Yoon, Dae Ho Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2018
Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical TrialsD Ross Camidge, Dong-Wan Kim, Marcello Tiseo, et al.The New England Journal of Medicine|April 10, 2024
Alectinib in Resected ALK-Positive Non-Small-Cell Lung CancerYi-Long Wu, Rafal Dziadziuszko, Jin Seok Ahn, et al.Pageof 34